168 related articles for article (PubMed ID: 30366515)
1. Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study.
Al-Husseini MJ; Saad AM; El-Shewy KM; Nissan NE; Gad MM; Alzuabi MA; Samir Alfaar A
Int J Neurosci; 2019 May; 129(5):447-454. PubMed ID: 30366515
[TBL] [Abstract][Full Text] [Related]
2. Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis.
Wen J; Chen W; Zhu Y; Zhang P
BMC Cancer; 2021 Jan; 21(1):81. PubMed ID: 33468109
[TBL] [Abstract][Full Text] [Related]
3. Impact of prior malignancy on outcomes of stage IV esophageal carcinoma: SEER based study.
Saad AM; Al-Husseini MJ; Elgebaly A; Aboshady OA; Salahia S; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2018 Apr; 12(4):417-423. PubMed ID: 29316808
[TBL] [Abstract][Full Text] [Related]
4. Impact of Prior Malignancy on Survival Outcomes of Stage IV Pancreatic Adenocarcinoma: SEER-Based Cohort.
Al-Husseini MJ; Saad AM; Turk T; Tabash MA; Abdel-Rahman O
J Gastrointest Cancer; 2019 Dec; 50(4):794-800. PubMed ID: 30105523
[TBL] [Abstract][Full Text] [Related]
5. Prior malignancies in patients harboring glioblastoma: an institutional case-study of 2164 patients.
Zacharia BE; DiStefano N; Mader MM; Chohan MO; Ogilvie S; Brennan C; Gutin P; Tabar V
J Neurooncol; 2017 Sep; 134(2):245-251. PubMed ID: 28551847
[TBL] [Abstract][Full Text] [Related]
6. Does the choice of antiepileptic drug affect survival in glioblastoma patients?
Knudsen-Baas KM; Engeland A; Gilhus NE; Storstein AM; Owe JF
J Neurooncol; 2016 Sep; 129(3):461-469. PubMed ID: 27377653
[TBL] [Abstract][Full Text] [Related]
7. Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme: a Surveillance Epidemiology and End Results (SEER) population analysis.
Thumma SR; Fairbanks RK; Lamoreaux WT; Mackay AR; Demakas JJ; Cooke BS; Elaimy AL; Hanson PW; Lee CM
World J Surg Oncol; 2012 May; 10():75. PubMed ID: 22553975
[TBL] [Abstract][Full Text] [Related]
8. Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study.
Zhu P; Du XL; Lu G; Zhu JJ
Oncotarget; 2017 Jul; 8(27):44015-44031. PubMed ID: 28467795
[TBL] [Abstract][Full Text] [Related]
9. Patterns of glioblastoma treatment and survival over a 16-years period: pooled data from the German Cancer Registries.
Efremov L; Abera SF; Bedir A; Vordermark D; Medenwald D
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3381-3390. PubMed ID: 33743072
[TBL] [Abstract][Full Text] [Related]
10. Effect of marital status on survival in glioblastoma multiforme by demographics, education, economic factors, and insurance status.
Xie JC; Yang S; Liu XY; Zhao YX
Cancer Med; 2018 Aug; 7(8):3722-3742. PubMed ID: 30009575
[TBL] [Abstract][Full Text] [Related]
11. Risk of subsequent cancer among pediatric, adult and elderly patients following a primary diagnosis of glioblastoma multiforme: a population-based study of the SEER database.
Li X; Li Y; Cao Y; Li P; Liang B; Sun J; Feng E
Int J Neurosci; 2017 Nov; 127(11):1005-1011. PubMed ID: 28288541
[TBL] [Abstract][Full Text] [Related]
12. Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe).
Mrugala MM; Engelhard HH; Dinh Tran D; Kew Y; Cavaliere R; Villano JL; Annenelie Bota D; Rudnick J; Love Sumrall A; Zhu JJ; Butowski N
Semin Oncol; 2014 Oct; 41 Suppl 6():S4-S13. PubMed ID: 25213869
[TBL] [Abstract][Full Text] [Related]
13. Does a history of malignancy impact the survival of a subsequent endometrial adenocarcinoma? Should clinical trials eligibility criteria be revisited?
Mohamed HH; Ibrahim Sokkar M; Afifi AM; Saad AM; Albarouki S; Al-Husseini MJ
J Obstet Gynaecol; 2020 Feb; 40(2):233-239. PubMed ID: 31352852
[TBL] [Abstract][Full Text] [Related]
14. Patient and treatment factors associated with survival among adult glioblastoma patients: A USA population-based study from 2000-2010.
Pan IW; Ferguson SD; Lam S
J Clin Neurosci; 2015 Oct; 22(10):1575-81. PubMed ID: 26122381
[TBL] [Abstract][Full Text] [Related]
15. Treatment and survival of patients harboring histological variants of glioblastoma.
Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
[TBL] [Abstract][Full Text] [Related]
16. Impact of particular antiepileptic drugs on the survival of patients with glioblastoma multiforme.
Guthrie GD; Eljamel S
J Neurosurg; 2013 Apr; 118(4):859-65. PubMed ID: 23176328
[TBL] [Abstract][Full Text] [Related]
17. The impact of inpatient rehabilitation on function and survival of newly diagnosed patients with glioblastoma.
Roberts PS; Nuño M; Sherman D; Asher A; Wertheimer J; Riggs RV; Patil CG
PM R; 2014 Jun; 6(6):514-21. PubMed ID: 24384359
[TBL] [Abstract][Full Text] [Related]
18. Influence of insurance status on survival of adults with glioblastoma multiforme: A population-based study.
Rong X; Yang W; Garzon-Muvdi T; Caplan JM; Hui X; Lim M; Huang J
Cancer; 2016 Oct; 122(20):3157-3165. PubMed ID: 27500668
[TBL] [Abstract][Full Text] [Related]
19. Glioblastoma multiforme (GBM) in the elderly: initial treatment strategy and overall survival.
Glaser SM; Dohopolski MJ; Balasubramani GK; Flickinger JC; Beriwal S
J Neurooncol; 2017 Aug; 134(1):107-118. PubMed ID: 28527010
[TBL] [Abstract][Full Text] [Related]
20. Impact of gender on the survival of patients with glioblastoma.
Tian M; Ma W; Chen Y; Yu Y; Zhu D; Shi J; Zhang Y
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30305382
[No Abstract] [Full Text] [Related]
[Next] [New Search]
